DPEP-1 Binding Compositions and Methods of Use
US-2024108686-A1 · Apr 4, 2024 · US
US9044486B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9044486-B2 |
| Application number | US-93596709-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 2, 2009 |
| Priority date | Apr 2, 2008 |
| Publication date | Jun 2, 2015 |
| Grant date | Jun 2, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a method for treatment and/or prophylaxis of FIP (feline infectious peritonitis) in cats. The method is performed by administering to a cat a composition comprising a therapeutic and/or prophylactic amount of a cysteine protease inhibitor. The cysteine protease inhibitor can be a selective cathepsin B inhibitor. Also provided is a method for inhibiting FIPV (Feline infectious peritonitis virus) replication. The method comprises contacting a cell infected with FIPV with a cysteine protease inhibitor in an amount effective to inhibit replication of FIPV. It is expected the method will be effective for therapy or prophylaxis of FIP in any species of cat and will be effective against any strain of feline coronavirus.
Opening claim text (preview).
We claim: 1. A method for treatment of Feline infectious peritonitis (FIP) comprising administering to a cat infected with feline infectious peritonitis virus (FIPV) an effective amount of a selective cathepsin B inhibitor such that at least one FIP symptom selected from the group consisting of: fluctuating fever that is unresponsive to antibiotics or corticosteroids, effusion, peritoneal inflammation, vomiting, diarrhea, icterus, and combinations thereof, is reduced, wherein the s…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.